Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J’s Zytiga for Prostate Cancer Too Expensive, U.K. Cost Agency Says
J&J’s Zytiga for Prostate Cancer Too Expensive, U.K. Cost Agency Says
J&J’s Zytiga for Prostate Cancer Too Expensive, U.K. Cost Agency Says
Submitted by
admin
on February 2, 2012 - 9:12am
Source:
Bloomberg
News Tags:
JNJ
Zytiga
prostate cancer
UK
Headline:
J&J’s Zytiga for Prostate Cancer Too Expensive, U.K. Cost Agency Says
Do Not Allow Advertisers to Use My Personal information
